Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Novo Nordisk A/S (NVO)

63.85   0.34 (0.54%) 02-21 16:02
Open: 63.74 Pre. Close: 63.51
High: 64.05 Low: 63.52
Volume: 873,502 Market Cap: 151303M
Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company's business segments include, diabetes and obesity care, and biopharmaceuticals.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 64.122 - 64.377 64.377 - 64.596
Low: 62.807 - 63.125 63.125 - 63.399
Close: 63.305 - 63.82 63.82 - 64.263

Technical analysis

as of: 2020-02-21 4:32:33 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 75.71     One year: 88.43
Support: Support1: 61.71    Support2: 59.79
Resistance: Resistance1: 64.82    Resistance2: 75.71
Pivot: 63.17
Moving Average: MA(5): 63.81     MA(20): 62.52
MA(100): 57.36     MA(250): 52.99
MACD: MACD(12,26): 1.12     Signal(9): 1.17
Stochastic oscillator: %K(14,3): 76.64     %D(3): 78.96
RSI: RSI(14): 61.95
52-week: High: 64.82  Low: 46.47  Change(%): 29.2
Average Vol(K): 3-Month: 131548  10-Days: 98106

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NVO has closed below upper band by 35.1%. Bollinger Bands are 7.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 21 Feb 2020 18:55:00 +0000
A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward

Fri, 21 Feb 2020 18:42:00 +0000
Oscar Health Cuts Co-Pays on About 100 Drugs to $3

Sun, 16 Feb 2020 15:00:00 +0000
Validea's Top Five Healthcare Stocks Based On Warren Buffett - 2/16/2020

Thu, 13 Feb 2020 13:00:00 +0000
Better Buy: Abbott Laboratories vs. Novo Nordisk

Sat, 08 Feb 2020 12:00:00 +0000
Is Amgen a Stock to Buy?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 2350.00
Shares Float (M) 1680.00
% Held by Insiders 0.01
% Held by Institutions 9.61
Shares Short (K) 5000
Shares Short P. Month (K)

Stock Financials

EPS 2.460
Book Value (p.s.) 3.080
PEG Ratio 2.49
Profit Margin 31.92
Operating Margin
Return on Assets (ttm) 28.3
Return on Equity (ttm) 71.2
Qtrly Rev. Growth 9.0
Gross Profit (p.s.) 43.600
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 2.60
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E 25.96
P/E Growth Ratio 0.01
P/BV 20.73
P/S
P/CF

Dividends & Splits

Dividend 1.230
Dividend Yield 0.02
Dividend Pay Date 2020-04-06
Ex-Dividend Date 2020-03-26
Forward Dividend 1.570
Last Split Date 2014-01-08
Last Split Ratio 5
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.